iBio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for iBio, Inc. (IBIO) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Jun 2024Jun 2023Jun 2022Jun 2021
Current Assets
Cash and Cash Equivalents8.5814.214.3022.6896.97
Short-Term Investments0.000.000.0010.8519.57
Cash & Short-Term Investments8.5814.214.3033.5296.97
Accounts Receivable0.110.711.711.000.43
Inventory0.000.000.003.900.03
Other Current Assets1.030.7518.071.555.10
Total Current Assets9.7215.7026.2645.07104.60
Non-Current Assets
Property, Plant & Equipment (Net)5.286.377.554.4434.74
Long-Term Investments1.310.000.000.000.00
Intangible Assets6.855.375.394.850.95
Other Non-Current Assets0.030.220.2543.415.18
Total Non-Current Assets13.4613.0414.9054.3137.25
Total Assets23.1928.7341.2199.41146.97
Current Liabilities
Accounts Payable2.192.396.414.265.26
Short-Term Debt1.310.2212.9422.160.60
Current Portion of Long-Term Debt0.770.220.000.000.60
Accrued Liabilities0.472.030.413.763.00
Deferred Revenue0.000.200.000.100.42
Other Current Liabilities2.611.571.940.061.67
Total Current Liabilities6.113.8422.1130.446.65
Non-Current Liabilities
Long-Term Debt2.203.573.723.5131.76
Other Non-Current Liabilities0.000.000.161.970.60
Total Non-Current Liabilities2.203.573.725.4932.36
Total Liabilities8.317.4125.8335.9238.40
Stockholders' Equity
Common Stock0.020.010.000.010.01
Retained Earnings-332.22-313.85-288.94-223.93-173.69
Accumulated Other Comprehensive Income0.000.000.00-0.21-0.06
Additional Paid-in Capital347.09335.16304.32287.62282.27
Minority Interest0.000.000.000.00-0.02
Shares Outstanding19.358.621.020.440.00
Total Stockholders' Equity14.8821.3215.5963.49108.57
Total Liabilities & Equity23.1928.7341.2199.41146.97